Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Thomas Jefferson University
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
I. Examine the efficacy of messaging for adjuvant hormone therapy compliance promotion (mAHT-CaP) in a randomized control trial (RCT) design.
SECONDARY OBJECTIVES:
I. Conduct mediator analyses of intervention efficacy..
EXPLORATORY OBJECTIVES:
I. Explore whether age (=\< 45 versus \[vs.\] \> 45 at diagnosis) and race/ethnicity (white vs. non-white) moderate intervention effects on medication adherence and symptom distress.
OUTLINE:
PHASE I: Participants attend focus groups on adherence to hormone therapy.
PHASE II: Participants are randomized to 1 of 2 groups.
GROUP I: Participants receive text messages twice weekly for 6 months to remind and motivate participants about adjuvant hormonal therapy (AHT) adherence.
GROUP II: Participants receive usual care.
After completion of study, participants are followed up at 3, 6, and 12 months.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Woman diagnosed with stage I-III breast cancer (BCa).
Hormone receptor positive tumor.
Completed local definitive treatment (i.e., surgery chemotherapy, radiation).
Within 3 month of initiation of a new adjuvant hormonal therapy (AHT) regimen.
At least 12 months of AHT recommended.
Able to read and understand English.
Able to provide informed consent.
Have a mobile device with text (TXT) capability.
Know or willing to learn how to use TXT.
You may not be if
Cognitive impairment documented in the electronic medical record (EMR), biological variables (sex).